AMISTAD II
AMISTAD II
Acute Myocardial Infarction Study of Adenosine II. A trial evaluating adenosine as an adjunct to thrombolytic reperfusion in decreasing the size of MIss,
Primary endpoint
Mortality, new heart failure.
Conclusion
Somewhat helpful at higher doses but not statistically significant.